Your browser doesn't support javascript.
loading
Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy.
Yang, Junyu; Gao, Chong; Liu, Miao; Liu, Yao-Chung; Kwon, Junsu; Qi, Jun; Tian, Xi; Stein, Alicia; Liu, Yanjing V; Kong, Nikki R; Wu, Yue; Yin, Shenyi; Xi, Jianzhong; Chen, Zhiyuan; Kumari, Kalpana; Wong, Hannan; Luo, Hongbo; Silberstein, Leslie E; Thoms, Julie A I; Unnikrishnan, Ashwin; Pimanda, John E; Tenen, Daniel G; Chai, Li.
Affiliation
  • Yang J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gao C; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Liu M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Liu YC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kwon J; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tian X; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Stein A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Liu YV; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Kong NR; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Wu Y; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Yin S; State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China.
  • Xi J; State Key Laboratory of Natural and Biomimetic Drugs, Institute of Molecular Medicine, Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China.
  • Chen Z; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kumari K; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Wong H; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Luo H; Joint Program in Transfusion Medicine, Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Silberstein LE; Joint Program in Transfusion Medicine, Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Thoms JAI; School of Medical Sciences and Lowy Cancer Research Centre, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
  • Unnikrishnan A; Prince of Wales Clinical School and Lowy Cancer Research Centre, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
  • Pimanda JE; School of Medical Sciences and Lowy Cancer Research Centre, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
  • Tenen DG; Prince of Wales Clinical School and Lowy Cancer Research Centre, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
  • Chai L; Department of Hematology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Cancer Res ; 81(23): 6018-6028, 2021 12 01.
Article in En | MEDLINE | ID: mdl-34593523

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic / DNA Methylation / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2021 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic / DNA Methylation / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2021 Document type: Article Country of publication: Estados Unidos